CAS RN: 88285-82-9
N,N-dibenzyl-1-(oxiran-2-yl)MethanaMine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251029
100mg / 250mg / 1g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 88285-82-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
88285-82-9 / N,N-dibenzyl-1-(oxiran-2-yl)methanamine
Standard CAS: 88285-82-9
Multi CAS: No
Basic Information
copy
CAS
88285-82-9 copy
Multi CAS
No copy
Molecular Formula
C17H19NO copy
Molecular Weight
253.340000 copy
Exact Mass
253.146664 copy
InChI
InChI=1S/C17H19NO/c1-3-7-15(8-4-1)11-18(13-17-14-19-17)12-16-9-5-2-6-10-16/h1-10,17H,11-14H2 copy
InChIKey
NJVDPMFWASDKDP-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
19 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.29 copy
Rotatable bonds
6 copy
H-bond acceptors
2 copy
Molar refractivity
76.74 copy
TPSA
15.77 copy
LogP / Solubility
WLOGP
3.09 copy
MLOGP
2.72 copy
XLogP3
2.9 copy
Consensus LogP
2.9 copy
Log S (ESOL)
-3.43 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.87 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-4.59 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.07 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
2 copy